Glypican-1-targeted and gemcitabine-loaded liposomes enhance tumor-suppressing effect on pancreatic cancer
Figure 1.Characterization of GPC1-LP (GEM). (A) Size distributions of GPC1-LP (GEM) determined by dynamic light scattering. (B) Cumulative drug release profiling of LP (GEM) and GPC1-LP (GEM) in phosphate-buffer saline (PBS, pH 7.4 and pH 5.0).